The Academy of Managed Care Pharmacy is testing a plan to have drugmakers submit evidence-based outcomes analyses when seeking formulary inclusion.
It's long been said that PPOs, by their varied nature, can't be held to the same quality yardsticks as HMOs. Yet, in time, something will have to suffice.
With the ever-rising cost of prescription drugs generating an outcry to reform Medicare, PhRMA's president finds himself in the eye of the storm.
It happened in the slump of the early 1990s, and it could very well happen again. Managed care feasts while other industries starve. People will still get sick, even in bad times.
Many hospitals already have some variety of emergency diagnostic and treatment units. HMOs and physicians should welcome this level of care.
The amount of fraud in the health care system is staggering, but computer analysis can help reduce the level. Here is one company's strategy.
Gregory J. Borca
John A. Marcille
Systems & Software
Joyce R. Ochs
Michael S. Victoroff, M.D.
Managed Care Outlook